Recruiting
Phase 3

Faricimab & PRP vs. Vitrectomy & Endolaser

Sponsor:

Jaeb Center for Health Research

Code:

NCT06790784

Conditions

Proliferative Diabetic Retinopathy (PDR)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vitrectomy

Endolaser

Faricimab

Panretinal Photocoagulation (PRP)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by Jaeb Center for Health Research on 2025-10-03.